Purpose: Monte Carlo methods were used to assess bow the value of outcome comparisons depends on the number of patients per provider.
Risk-adjusted comparisons of outcomes are an important tool to assess quality of care. They can help providers improve care [1] , influence the selection of providers by third-party payers [2] or patients [3, 4] , and affect reimbursements [5] . As a means to assess performance, outcome comparisons have been performed nationally [6, 7] , by several states [1, 3, 4, 8, 9] , and by some communities [10] [11] [12] .
Outcome comparisons are often criticized, however. The most frequent criticism is that differences in outcomes among providers may be due to differences in unexplained patient risk rather than differences in quality of care [13] [14] [15] [16] [17] . A second common criticism is that the outcomes chosen may not reflect important aspects of care [18] [19] [20] [21] [22] . Another concern about outcomes comparisons that has been mentioned [18, 19, 23] , but not thoroughly explored, is that they may lack precision because of random variation.
The precision of outcome assessment has been measured using confidence intervals. These intervals provide likely bounds for either the rate of an adverse outcome or the difference between the observed and expected rate of an adverse outcome. Usually, however, the assessment of the adverse outcome rate for a given provider depends not on the rate itself but how the rate compares to others. For example, patients may select providers with the lowest rates of adverse outcomes, or health care organizations may want to eliminate from the organization providers with the highest rates. Confidence intervals do not quantify the precision for making these types of decisions.
The factor that most influences the precision of outcome studies is the number of patients per provider. In the present study, we generated simulated data to examine how the number of patients per provider affects the relationship between a provider's true relative quality and the provider's apparent relative quality. The study does not develop precise criteria for a minimal number of patients per provider necessary to assess the relationship in any data set It does, however, show how the number of patients per provider affects the relationship in some representative data sets, and it presents a method for estimating the random component of the variation in any real data set.
METHODS
A probabilistic model was used for the computergenerated data. In this model, the patients for each physician or hospital provider were assumed to have an underlying probability of an adverse outcome that depended only on the provider; the observed rate of adverse outcomes was a random realization of this underlying probability. The provider's true relative quality was measured by the provider's relative probability of an adverse outcome, and the provider's apparent or observed relative quality was measured by the observed relative rates of an adverse outcome. To simplify the model, patient risk was kept constant.
The study examined how the number of patients per provider affected the relationship between the provider's true and observed relative quality. The design of the study can be summarized in three steps:
(1) As described in the next two sections, underlying provider probabilities of an adverse outcome were generated so that the mean and variance of these rates were likely to correspond to the mean and variance of underlying provider mortality rates in two well-known data sets used for outcome comparisons.
(2) Observed rates of adverse outcomes were randomly generated from the underlying probabilities. In the generated data sets, the number of patients per provider varied from 100 to 1000, and 1000 samples were generated for a given number of patients per provider.
(3) For a given number of patients per provider, we found the relationship between the relative values of the observed adverse outcome rates and the relative values of the underlying probabilities of adverse outcomes. As described below, several methods were used to characterize this relationship.
PATIENT DATA SETS
We designed the computer generated data to correspond to patient data sets that often have been analyzed in the literature and are representative of other data sets likely to be used for quality assessment. One patient data set combined New York and Pennsylvania data on mortality rates for coronary artery bypass surgeons [3, 4] . A second data set simulated hospital mortality rates for Medicare patients [6] .
Each of these data sets included the ratio of the observed to predicted rate of an adverse outcome for each provider. These ratios take into account patient risk. The risk-adjusted mortality rate for the rth provider (MRD was defined as MR t = R t x MRQ where MRQ is the mortality rate for all patients combined, and Rt is the ratio of the observed to predicted rate of an adverse outcome for the rth provider. For each data set, we computed the mean and standard deviation of these adjusted rates.
GENERATING SIMULATED DATA SETS
A simulated data set consisted of a given number of providers, each with a given number of patients. All providers in a given data set had the same number of patients to make the results easier to interpret. Each provider had a fixed underlying probability of an adverse outcome, p h that was used to generate an observed adverse outcome rate for that provider,/*/. One thousand pi values were generated for the fth provider with a given number of patients. The number of patients per provider was varied from 100 to 1000.
There were 100 providers in the simulated data set corresponding to the CABG surgery patient data and 300 providers in the simulated data set corresponding to the Medicare patient data. Using more than 300 providers did not affect the results. Only one set of pfi was used for the simulated CABG surgeon data. This set was created with the SAS RANNOR function [24] so that the mean and variance of the observed mortality rates in the actual CABG surgeon data set would equal the mean and variance of the simulated rates with the same average number of patients per provider. This same process was used to create thep/s for the Medicare data set.
The number of adverse outcomes for a provider with a given Pi and a given number of patients was generated with the SAS RANBIN function [24] . The adverse outcome rate for that provider, p t , was computed as the number of adverse outcomes for that provider divided by the number of patients.
We only reported results for simulated data that were generated from one set of pp. However, three different The relationship of the value of outcome comparisons to the number of patients per provider 249 sets of pfi from the same normal distribution gave very similar results.
EXAMPLE OF SIMULATION
An example of generating observed rates is shown in Table 1 for four providers. Each of the providers in the example was assumed to have 200 observations. The p t for provider 1 in this example was 1.69%, i.e. for each of the 200 observations for provider 1, the probability of an adverse outcome was 1.69%. In the first sample, provider 1 had four adverse outcomes, in the second, two adverse outcomes, and in the third, two adverse outcomes. The values of pi and the number of adverse outcomes for three samples are also shown for providers 2, 3, and 4.
MEASURING THE UTILITY OF OBSERVED OUTCOMES
We used four measures of how well the provider's apparent relative quality reflected the provider's true relative quality. One was r 2 , the square of the correlation between the observed rate of an adverse outcome and the underlying probability of an adverse outcome. The value of r 2 is the percentage of variation in the observed adverse outcome rate that can be accounted for by the underlying probability of an adverse outcome. If the providers have the same relationship with respect to their observed rates of adverse outcomes as they do with respect to their underlying probabilities of an adverse outcome, then the value of r 2 will be 1.00. If there is no relationship, the value of r 2 will be 0.00. This measure is the best indication of how well the relative observed rates reflected the relative quality of the providers.
A similar utility measure was the variation in one set of observed rates that was explained by another set of observed rates. This measure was used to determine how well performance at one time period may be used to predict performance at a later time period.
Other utility measures evaluated a criterion for selecting the best or worst group of providers. One criterion evaluated was that the provider had a rate of adverse outcomes in the lowest 10% of all physicians. We computed the positive predictive value of this criterion as a means for identifying best providers, those with an underlying probability of an adverse outcome in the lowest 10%, or good providers, those with an underlying probability of an adverse outcome rate in the lowest 25%.
Since there were ties for observed adverse outcome rates, more than 10% of providers had an observed adverse outcome rate that was no worse than the lowest 10%. A similar criterion, an observed adverse outcome rate in the highest 10% of all providers, was evaluated as a method to identify the worst providers (underlying probabilities in the highest 10%) or bad providers (underlying probabilities in the highest 25%). All measures of utility of a given outcome measure for a given sample size were evaluated in 1000 samples. We reported the average value of the utility measure in the 1000 samples.
RESULTS
In Table 2 , the patient data sets and the simulated observed data sets are compared. Two patient data sets for mortality following CABG surgery are shown in the table, one for New York and one for Pennsylvania. The mean and standard deviation of the simulated observed rates were generated so that they would be between the values for the two states. Because the observed rates had a random variation component, the standard deviation was greater for the observed rates than for the underlying probabilities.
Adjustment made a greater difference in the standard deviation of the mortality rate for the Medicare mortality data than for the CABG surgery data. After adjustment, the standard deviation of adverse outcome rates in the Medicare data set was almost the same as in the CABG surgery data set. The average standard deviation of the simulated observed rates of the CABG surgeon data set A.J. Haitzelal. Patients Per Surgeon FIGURE 1. Percentage of variation in observed adverse outcome rates explained by underlying adverse outcome rates or by other observed adverse outcome rates.
was very similar to the standard deviation of the simulated observed rates in the Medicare patient data set.
The relationship between the number of patients per CABG surgeon and the percent of variation in the observed rates that is explained by the underlying probabilities is shown in Fig. 1 . The underlying probabilities explained 30% of the variation when there were 100 patients, 46% of the variation when there were 200 patients, and 63% of the variation when there were 400 patients. The variation that was not explained by the underlying probabilities is due to chance.
To interpret these results, it is necessary to know the number of surgeons who have a given number of patients. We obtained this information only from the Pennsylvania data because the New York data did not include surgeons who performed less than 200 cases in 3 years. In Pennsylvania 58% of the surgeons perform less than 100 surgeries a year, and 99% perform less than 400 surgeries a year. Over 3 years, 65% of the physicians performed 200 or more surgeries and 3.5% more than 600 surgeries. Figure 1 also shows the percent of variation in adverse outcome rates for one simulation that can be explained by the adverse outcome rates in another simulation. It can be shown mathematically that, on average, this percentage is the square of the percentage of the variation in the observed rates that are predicted by the underlying rates. Even for providers who have as many as 200 patients, only 22% of the variation in another simulation can be predicted. These results suggest how well a physician's adverse outcome rate in one period may predict his or her outcome rate for the next time period. Clearly, the prediction is accurate only if there are a very large number of patients.
ACCURACY OF IDENTIFYING BEST SURGEONS
The criterion for identifying a best surgeon was an adverse outcome rate in the lowest 10th percentile. The chance that a surgeon who met this criterion would be a good or best surgeon, i.e. the positive predictive value of the criterion, is shown in Fig. 2 . When there were 200 patients per surgeon, the criterion had a 45% chance of selecting a best surgeon, but an almost 70% chance of selecting at least a good surgeon. The sensitivity for identifying best surgeons is 62.5%, and the specificity is 91.6%. We included only the positive predictive values in a graph because patients are most concerned that they have correctly identified a best surgeon. At 600 patients per surgeon (a number achieved by only 3.5% of Pennsylvania surgeons in 3 years), the positive predictive value for identifying best surgeons is 66.4%, and the positive predictive value for identifying good surgeons is 88.9%. The sensitivity is 74.4%, and the specificity is 95.8%.
As shown in the figure, the positive predictive values were somewhat lower for identifying worst surgeons than best surgeons. The positive predictive values for identifying worst surgeons were 31.3% for 100 patients, 39.1% for 200 patients, and 63.9% for 1000 patients. The corresponding sensitivities and specificities were 42.4% and 89.7%, 48.7% and 91.5%, and 68.1% and 95.7%. The relationship of the value of outcome comparisons to the number of patients per provider 251 for identifying worst surgeons than best surgeons is that worst surgeons have higher probabilities of an adverse outcome and therefore a greater binomial sampling variation than do best surgeons.
COMPARISON OF r 2 FROM SIMULATED DATA AND FROM AN EQUATION
The equation shown below to estimate r 2 was derived in the Appendix. 
COMPARISON OF RESULTS BY DATA SET
To illustrate how the results may vary across data sets, we compared the results for the CABG data and Medicare Hospital Mortality data. As shown in Table 3 , the variation in the underlying probability of adverse outcomes was very similar for each of the two simulated data sets (1.12 for the CABG surgery data set and 1.19 for the HCFA hospital data set). The average probability, however, was much higher in the HCFA hospital data set than in the CABG surgery data set, 9.17% compared to 3.05%. Because of the higher mortality rates in the HCFA data set, the percentage of variation explained and the positive predictive values were larger for the CABG data set. For example, when there were 400 patients per provider, the percentage of variation in the observed rates explained by the underlying probability was 63% for the simulated CABG data and 40% for the simulated Medicare data. To achieve an r 2 of 75% required 1800 patients per provider in the medicine data set but only 800 patients per provider in the CABG data set.
For a given number of patients per provider, the positive predictive values were also higher in the CABG surgery data set than in the Medicare data set. For example, when there were 400 patients per provider, the positive predictive value of using an adverse outcome rate in the lowest 10% for identifying a best surgeon was 59.3% in the CABG surgery data set and 42.8% in the Medicare data set.
ESTIMATING r 2 IN REAL DATA SETS
In the simulation study, we could find the value of r 2 from equation (1) where k is the number of providers and si is the variance of the observed rates. The calculations are shown as follows. If the variance of the mortality rates for a given As an indication of the ability of this equation to estimate r 2 , we tested it on data simulating hospitals with 100, 400, and 1000 patients, as shown in Table 4 . The distribution of the estimated r 2 is shown with the correct value of r 2 . When there were 400 patients per provider, 90% of the estimates for r 2 were in a narrow range, 55.4-68.8%. Although a given estimate of r 2 will have some error, it will usually be sufficiently precise to give a good qualitative indication of the value of r 2 for a given data set.
DISCUSSION
We evaluated the relationship between the number of patients per provider and the reliability of comparing mortality rates. The evaluation was performed using two computer-generated data sets that simulated important examples of data sets used for outcome comparisons: data on CABG surgeons from New York and Pennsylvania and Medicare hospital mortality data. In the simulated data sets, variation among providers was due only to variation in quality and random variation; there was no variation due to inadequate risk-adjustment.
A significant percentage of the outcome variation in the simulated data sets was due to chance. It required at least 400 cases per surgeon in the CABG surgery data set and 1000 cases per hospital in the Medicare data set for the percentage of variation due to random factors to be less than 40%. Since comparisons of hospitals often involve a subset of patients, e.g. those who have a myocardial infarction, there may be not be enough patients in the hospitals to obtain an accurate assessment of their relative underlying probabilities of adverse outcomes.
FACTORS INFLUENCING THE VALUE OF RISK-ADJUSTED OUTCOMES
Sample size greatly influenced the precision of riskadjusted outcomes as measures of quality of care. With increasing sample sizes, there was decreasing random variation and increasing positive predictive values for identifying the best or worst providers. It is clear from the differences in the results for the two simulated data sets, however, that the validity of risk-adjusted outcome comparisons was affected by factors other than sample size. Equation (1) can be used to explain the different results for the two data sets. As shown in this equation, the percentage of variation in observed rates that is not due to chance, i.e. r 2 , is increased if the underlying probabilities have a greater variance and are closer to zero. The value of r was higher in the simulated CABG surgery data set than the Medicare hospital data set because the latter data set had higher adverse outcome rates and no corresponding increase in the variation of the underlying adverse outcome rates. In general, there is likely to be less underlying variation among hospital or other institutional providers after adjusting for patient risk than among individual physicians since the results for institutional providers are the average of the results of many individual physicians. Variation among hospitals will be further reduced if outcomes are compared for all patients (e.g. hospital adverse outcome rate) rather than for specific conditions (e.g. adverse outcome rate for myocardial infarction patients).
The value of r 2 can be estimated easily and with reasonable accuracy using equation (2). To estimate r 2 , it is necessary to know the average rate of adverse outcomes, the variance in the observed rates of adverse outcomes, and the number of patients per provider. A low estimate of r 2 can be obtained by substituting into equation (2) the number of patients for providers with relatively few patients, e.g. in the lowest 10th percentile. If this estimated value of r 2 is low, e.g. less than 50%, then comparison involving providers with the low sample size will be inadequate, and these providers should be eliminated before making comparisons.
CONCLUSIONS
The results from this study suggest that, even if risk adjustment is adequate and the outcome measure is appropriate, limitations due to sample size may remain. Although the imprecision in statistical estimates due to small sample sizes is true in all statistical studies, the effect of small sample size has been largely ignored in studies of outcomes research. The present study quantified the degree that the sample size may limit the accuracy of quality assessment in certain types of commonly used data sets. The results suggest that, unless the number of patients per provider is large, judgments of the quality of individual providers should be made cautiously and need to be substantiated with other evidence.
